SCHEMBL7347233

SCHEMBL7347233

N[C@@H]1CCC[C@@H]1[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7347230 1.00
SCHEMBL2272281 1.00
SCHEMBL2268627 1.00
SCHEMBL7348502 0.94
SCHEMBL7348503 0.94
SCHEMBL6157905 0.94
SCHEMBL7782125 0.78
SCHEMBL7866676 0.72
SCHEMBL12133538 0.72
SCHEMBL1350955 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015179743-A1 LIBRARY AND SCREENING APPROACH FOR IMPROVED CELL PENETRATING PEPTIDES GENZYME CORPORATION (US) 2015-11-26 WO claimed
US-5538997-A HIV PROTEINASE INHIBITORS SANDOZ LTD. (CH) 1996-07-23 US claimed
EP-0615969-A1 2,4-Diamino-3-hydroxycarboxylic acid derivatives SANDOZ LTD. (CH) 1994-09-21 EP claimed
US-11801311-B2 Inhibiting or downregulating glycogen synthase by creating premature stop codons using antisense oligonucleotides GENZYME CORPORATION (US) 2023-10-31 US disclosed
EP-3795687-A1 INHIBITING OR DOWNREGULATING GLYCOGEN SYNTHASE BY CREATING PREMATURE STOP CODONS USING ANTISENSE OLIGONUCLEOTIDES Genzyme Corporation (US) 2021-03-24 EP disclosed
US-20210030893-A1 INHIBITING OR DOWNREGULATING GLYCOGEN SYNTHASE BY CREATING PREMATURE STOP CODONS USING ANTISENSE OLIGONUCLEOTIDES GENZYME CORPORATION 2021-02-04 US disclosed
EP-3146050-B1 INHIBITING OR DOWNREGULATING GLYCOGEN SYNTHASE BY CREATING PREMATURE STOP CODONS USING ANTISENSE OLIGONUCLEOTIDES GENZYME CORP (US) 2020-08-12 EP disclosed
US-10682423-B2 Inhibiting or downregulating glycogen synthase by creating premature stop codons using antisense oligonucleotides GENZYME CORPORATION (US) 2020-06-16 US disclosed
CN-106459975-B Multiple oligonucleotide moieties on peptide carriers 建新公司 2020-03-27 CN disclosed
US-20190117794-A1 INHIBITING OR DOWNREGULATING GLYCOGEN SYNTHASE BY CREATING PREMATURE STOP CODONS USING ANTISENSE OLIGONUCLEOTIDES GENZYME CORPORATION 2019-04-25 US disclosed
US-20170182171-A1 MULTIPLE OLIGONUCLEOTIDE MOIETIES ON PEPTIDE CARRIER GENZYME CORPORATION 2017-06-29 US disclosed
US-20170182189-A1 INHIBITING OR DOWNREGULATING GLYCOGEN SYNTHASE BY CREATING PREMATURE STOP CODONS USING ANTISENSE OLIGONUCLEOTIDES GENZYME CORPORATION 2017-06-29 US disclosed
EP-3151841-A1 MULTIPLE OLIGONUCLEOTIDE MOIETIES ON PEPTIDE CARRIER Genzyme Corporation (US) 2017-04-12 EP disclosed
EP-3146050-A1 INHIBITING OR DOWNREGULATING GLYCOGEN SYNTHASE BY CREATING PREMATURE STOP CODONS USING ANTISENSE OLIGONUCLEOTIDES Genzyme Corporation (US) 2017-03-29 EP disclosed
WO-2015179741-A1 INHIBITING OR DOWNREGULATING GLYCOGEN SYNTHASE BY CREATING PREMATURE STOP CODONS USING ANTISENSE OLIGONUCLEOTIDES GENZYME CORPORATION (US) 2015-11-26 WO disclosed
WO-2015179742-A1 MULTIPLE OLIGONUCLEOTIDE MOIETIES ON PEPTIDE CARRIER GENZYME CORPORATION (US) 2015-11-26 WO disclosed
WO-2015179743-A1 LIBRARY AND SCREENING APPROACH FOR IMPROVED CELL PENETRATING PEPTIDES GENZYME CORPORATION (US) 2015-11-26 WO disclosed
US-5538997-A HIV PROTEINASE INHIBITORS SANDOZ LTD. (CH) 1996-07-23 US disclosed
EP-0615969-A1 2,4-Diamino-3-hydroxycarboxylic acid derivatives SANDOZ LTD. (CH) 1994-09-21 EP disclosed